New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 15, 2017 – Aclaris Therapeutics announced the FDA approval of Eskata (hydrogen peroxide) for the treatment of seborrheic keratoses (SK) that are raised.
Download PDF
Return to publications
